ODDB.org: Open Drug Database

Takeda Pharma AG - Edarbi 20mg, Tabletten

Swissmedic Registration	62158	Sequence	01
Product name	Edarbi 20mg	Description	Tabletten
ATC-Classification	C09CA09	ATC-Description	Azilsartan Medoxomil
Introduction of Sequence	31.08.2012

Composition

azilsartanum medoxomilum 20 mg ut azilsartanum medoxomilum kalicum 21.34 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 0.80 mg.

Packungsbestandteile

Galenic Form

Tablets

Active Agent	Dose
Azilsartanum Medoxomilum	20 mg

BAG: Active Agent	Dose
Azilsartanum Medoxomilum	20 mg

Inactive agents	Dose
Acidum Fumaricum
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
Hydroxypropylcellulosum
Magnesii Stearas
Mannitol
Sodium Hydroxide
Sodium	0.8 mg
Pro Compresso

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	28 Tablet(s)	19.37	37.50	B	SL	Yes
003	98 Tablet(s)	66.28	88.50	B	SL	Yes
016	14	PR	PR	B		Yes

2025	©ywesee GmbH